Off the wire
• Roundup: Undecided voters set to determine fate of elections in Turkey  • Ancient Chinese city Dali to charge visitors entry fee  • (Specialr for CAFS) Feature:Poverty-enemy to children rights in Kenya  • Dropping bid to suspend Israel from FIFA does not mean "give up the resistance"  • Xinhua Insight: Tax hikes assist China's anti-smoking efforts  • Lock-up shares worth 46.7 bln yuan to become tradable  • 1st LD-Writethru: Chinese president demands efforts to ensure public safety  • China opposes Carter's comments on construction in South China Sea  • Sri Lanka in talks with China over highway projects  • Beijing's largest reservior to receive "southern water"  
You are here: 　 Home

Number of contacts with China's first MERS patient rises to 47

Xinhua, May 30, 2015 Adjust font size:

The number of people who have close contacts with China's first Middle East Respiratory Syndrome (MERS) patient rose to 47 on Saturday, local health authority announced on Saturday night.

The man from the Republic of Korea (ROK), who was tested positive for the deadly MERS in south China's Guangdong Province on Friday, is still quarantined and receiving treatment at a hospital in Huizhou City, according to the provincial health and family planning commission.

He has got fever but is in stable condition, according to the commission.

Nine passengers who had close contacts with him reported to the commission after it issued a public notice on Friday, bringing the number of people who have contacts with him to 47. They are all under medical observation in isolation.

The man, 44, flew from the ROK to Hong Kong on Tuesday and entered Huizhou City via Shenzhen. He had close contact with MERS patients at home and expressed discomfort as early as May 21.

The patient is the son of the third confirmed MERS case in the ROK and the brother of the ROK's fourth confirmed case.

MERS is a respiratory illness caused by a new type of corona virus. The first case was identified in Saudi Arabia in 2012. There is no vaccine or treatment for the disease, which has a fatality rate of 40.7 percent. Endi